Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

The AACR Annual Meeting is the focal point of the cancer research community, where scientists, clinicians, other health care professionals, survivors, patients, and advocates gather to share the latest advances in cancer science and medicine. From population science and prevention; to cancer biology, translational, and clinical studies; to survivorship and advocacy; the AACR Annual Meeting highlights the work of the best minds in cancer research from institutions all over the world.
View all videos

AACR 2022

American Association for Cancer Research 2022 Meeting
08–13 April 2022 | New Orleans, LA
VJOncology avatar; VJ Oncology @VJOncology ·
April 19, 2024 1781291779913826750

Missing #AACR24? 🧬

…us too!

For exclusive coverage, interviews and all the latest in #Oncology visit us at 👉 http://VJOncology.com 👈

@AACR #oncology

Image for the Tweet beginning: Missing #AACR24? 🧬 …us too! For exclusive Twitter feed image.
Reply on Twitter 1781291779913826750 Retweet on Twitter 1781291779913826750 0 Like on Twitter 1781291779913826750 0 Twitter 1781291779913826750
VJOncology avatar; VJ Oncology @VJOncology ·
April 18, 2024 1780980922059264126

🎥We had the privilege of talking to @CharlesSwanton on the #BTOG24 keynote lecture surrounding the initiation of #lungcancer in response to the inhalation of air pollution

👀Interview coming soon to http://VJOncology.com - watch this space!

@BTOGORG #LCSM #NSCLC @TheCrick

Image for the Tweet beginning: 🎥We had the privilege of Twitter feed image.
Reply on Twitter 1780980922059264126 Retweet on Twitter 1780980922059264126 2 Like on Twitter 1780980922059264126 14 Twitter 1780980922059264126
VJOncology avatar; VJ Oncology @VJOncology ·
April 18, 2024 1780967192143536202

🎥We were delighted to catch up with @cpeedell on #lungcancer updates at #BTOG24 including whether there is a role for radiotherapy in extensive-stage #SCLC

👉Full interview coming soon to http://VJOncology.com

@BTOGORG #LCSM #NSCLC #LungCancer

Image for the Tweet beginning: 🎥We were delighted to catch Twitter feed image.
Reply on Twitter 1780967192143536202 Retweet on Twitter 1780967192143536202 3 Like on Twitter 1780967192143536202 6 Twitter 1780967192143536202
VJOncology avatar; VJ Oncology @VJOncology ·
April 18, 2024 1780906710992842782

🎥We had the pleasure of catching up with @AdamJanuszewski this morning to discuss the BTOG Therapeutics Symposium, ADCs in #lungcancer, and more at #BTOG24

👀Interview coming soon to http://VJOncology.com

@BTOGORG #LCSM #NSCLC #SCLC #LungCancer

Image for the Tweet beginning: 🎥We had the pleasure of Twitter feed image.
Reply on Twitter 1780906710992842782 Retweet on Twitter 1780906710992842782 2 Like on Twitter 1780906710992842782 4 Twitter 1780906710992842782
Load More

AACR 2022

American Association for Cancer Research 2022 Meeting
08–13 April 2022 | New Orleans, LA
The AACR Annual Meeting is the focal point of the cancer research community, where scientists, clinicians, other health care professionals, survivors, patients, and advocates gather to share the latest advances in cancer science and medicine. From population science and prevention; to cancer biology, translational, and clinical studies; to survivorship and advocacy; the AACR Annual Meeting highlights the work of the best minds in cancer research from institutions all over the world.
View all videos
VJOncology avatar; VJ Oncology @VJOncology ·
April 19, 2024 1781291779913826750

Missing #AACR24? 🧬

…us too!

For exclusive coverage, interviews and all the latest in #Oncology visit us at 👉 http://VJOncology.com 👈

@AACR #oncology

Image for the Tweet beginning: Missing #AACR24? 🧬 …us too! For exclusive Twitter feed image.
Reply on Twitter 1781291779913826750 Retweet on Twitter 1781291779913826750 0 Like on Twitter 1781291779913826750 0 Twitter 1781291779913826750
VJOncology avatar; VJ Oncology @VJOncology ·
April 18, 2024 1780980922059264126

🎥We had the privilege of talking to @CharlesSwanton on the #BTOG24 keynote lecture surrounding the initiation of #lungcancer in response to the inhalation of air pollution

👀Interview coming soon to http://VJOncology.com - watch this space!

@BTOGORG #LCSM #NSCLC @TheCrick

Image for the Tweet beginning: 🎥We had the privilege of Twitter feed image.
Reply on Twitter 1780980922059264126 Retweet on Twitter 1780980922059264126 2 Like on Twitter 1780980922059264126 14 Twitter 1780980922059264126
VJOncology avatar; VJ Oncology @VJOncology ·
April 18, 2024 1780967192143536202

🎥We were delighted to catch up with @cpeedell on #lungcancer updates at #BTOG24 including whether there is a role for radiotherapy in extensive-stage #SCLC

👉Full interview coming soon to http://VJOncology.com

@BTOGORG #LCSM #NSCLC #LungCancer

Image for the Tweet beginning: 🎥We were delighted to catch Twitter feed image.
Reply on Twitter 1780967192143536202 Retweet on Twitter 1780967192143536202 3 Like on Twitter 1780967192143536202 6 Twitter 1780967192143536202
VJOncology avatar; VJ Oncology @VJOncology ·
April 18, 2024 1780906710992842782

🎥We had the pleasure of catching up with @AdamJanuszewski this morning to discuss the BTOG Therapeutics Symposium, ADCs in #lungcancer, and more at #BTOG24

👀Interview coming soon to http://VJOncology.com

@BTOGORG #LCSM #NSCLC #SCLC #LungCancer

Image for the Tweet beginning: 🎥We had the pleasure of Twitter feed image.
Reply on Twitter 1780906710992842782 Retweet on Twitter 1780906710992842782 2 Like on Twitter 1780906710992842782 4 Twitter 1780906710992842782
Load More

Watch all AACR 2022 videos!

View all videos
4:21
Rationale and study design of CheckMate-649 biomarker analysis
Kohei Shitara • 14 Apr 2022
2:09
Future directions of research following the CheckMate-649 trial
Kohei Shitara • 14 Apr 2022
1:42
Effect of microbes on clinical outcomes of neoadjuvant treatment in patients with rectal cancer
Francisco Sanchez-Vega • 10 Apr 2022
1:56
MEDI5752: Novel PD-1/CTLA-4 bispecific checkpoint inhibitor for advanced solid tumors
Ben Tran • 21 Apr 2022

Breast cancer at AACR 2022!

View all
0:34
Unanswered questions in DCIS progression
Tanjina Kader • 11 Apr 2022
0:53
Mechanisms by which obesity leads to breast cancer
Kristy A. Brown • 10 Apr 2022
0:56
HER2-low status as a therapeutic target in advanced breast cancer
Changchuan Jiang • 10 Apr 2022
1:15
Challenges in TNBC
Lisa Carey • 11 Apr 2022

Lung cancer at AACR!

View all
1:10
Event-free survival results from CheckMate 816
David Carbone • 10 Apr 2022
0:41
Changing surgical approaches in lung cancer therapy
David Carbone • 10 Apr 2022
4:00
Designing clinical trials for precision oncology
Vivek Subbiah • 11 Apr 2022
0:50
Phase I study of TAK-676 + pembrolizumab following radiotherapy in late-line NSCLC, TNBC and SCCHN
Benjamin Cooper • 10 Apr 2022

Immuno-Oncology

View all
0:53
Strategies to enhance anti-tumor T cell response to immune checkpoint inhibitors in TNBC
Lisa Carey • 11 Apr 2022
0:47
BO-112: Enhancing immune-checkpoint inhibition in solid tumors
Ángel Alberich-Bayarri • 10 Apr 2022
2:29
Overcoming resistance to immunotherapy as first-line therapy in gastric cancer
Kohei Shitara • 7 Apr 2022
1:44
Intratumoral immunotherapy with BO-112 + pembrolizumab in patients with anti-PD1 refractory melanoma
Ángel Alberich-Bayarri • 10 Apr 2022
The content of VJOncology is intended for healthcare professionals